The global radiofrequency ablation devices market is anticipated to grow at a CAGR of 1.5% during the forecast period (2021-2027). The new and innovative RF ablation devices to support minimally invasive surgeries are a key factor driving the growth of the global radiofrequency ablation devices market. The key companies across the globe are highly inclined towards the adoption of different growth strategies including capacity expansion, mergers and acquisitions, new product launches, and product innovation to remain competitive in the marketplace. The various product launches of the key players are as follows:
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/radiofrequency-ablation-rf-devices-market
In November 2020, Abbott Laboratories has launched the IonicRF Generator. Iconic RF is a US FDA approved device to deliver a non-surgical, minimally invasive treatment for the management of pain in the nervous system. The IonicRF Generator is a radiofrequency ablation device that uses heat to target specific nerves and block pain signals from reaching the brain.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/radiofrequency-ablation-rf-devices-market
In February 2019, Medtronic Plc has launched the new Accurian radio frequency (RF) ablation system in the US, following 510(k) clearance from the country’s regulatory authority. With this launch the company has expanded its minimally invasive therapy portfolio. The new device is suitable for standard, pulsed and enhanced procedures. It has internally-cooled probes to create a lesion of various shapes, sizes and volumes.
Global Radiofrequency Ablation Devices Market Report Segment
By Component
- Catheter System
- Generator
- Accessories
By Application
- Oncology
- Cardiology
- Pain Management
- Others
Global Radiofrequency Ablation Devices Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Rest of the World
- Latin America
- Middle East & Africa
Company Profiles
- Abbott Laboratories, Inc.
- Alcon Laboratories, Inc.
- AngioDynamics, Inc.
- AtriCure, Inc.
- Boston Scientific Corp.
- BVM Medical Ltd.
- R. Bard, Inc. (a part of Becton, Dickinson & Co.)
- CONMED Corp.
- EDAP TMS SA
- HealthTronics, Inc.
- Hologic, Inc.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
